Primary study · included by 1 review
Evaluation of the Efficacy of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle for the Treatment of Nocturnal Bruxism: A Randomized Controlled Clinical Trial.
Shehri 2022 · Shehri Zaed Ghassan, Alkhouri Issam, Hajeer Mohammad Y, et al. · Cureus · 2022
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
EMG-based muscle activity, frequency and amplitude Botulinum toxin type A injection into masticatory muscles vs Placebo injection | Hedges g -0.84 [-1.13, -0.54] | 5 studies · 101 participants | GRADE not reported |
EMG-based muscle activity, frequency and amplitude Botulinum toxin type A injection into masticatory muscles vs Placebo injection · Primary post-treatment time points, typically 2–4 weeks | Hedges g -1.09 [-1.65, -0.54] | 5 studies · 101 participants | Low |
EMG-based muscle activity, frequency and amplitude Botulinum toxin type A injection into masticatory muscles vs Placebo injection | Hedges g -0.92 | 4 studies | GRADE not reported |
EMG-based muscle activity, frequency and amplitude Botulinum toxin type A injection into masticatory muscles vs Placebo injection | Hedges g -1.34 | 4 studies | GRADE not reported |
1 including review in total.